Shuwei Liu
机构:Shenyang Pharmaceutical University, Guangzhou University of Chinese Medicine, Shandong University of Technology, Inner Mongolia Agricultural University, Ningbo University of Technology, Beijing Technology and Business University, Jilin University, Sinolight (China), First Affiliated Hospital of Guangzhou University of Chinese Medicine, Theranostics (New Zealand), First Hospital of Jilin University, Taiyuan University of Technology · ORCID:0000-0002-9934-8183
发表论文 89 篇 · 总被引 1821 次 · h-index 25
代表论文
- Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11/GSH/GPX4 Antioxidant Axis (2025 · ACS Nano · 被引 91)
- CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis (2025 · Molecular Cancer · 被引 37)
- Intumescent flame retardant behavior of aryl Schiff base triazine piperazine char-forming agent with heat-induced cyclization self-crosslinking trait in polypropylene (2025 · Chemical Engineering Journal · 被引 33)
- Optimal scheduling of park-level integrated energy system considering multiple uncertainties: A comprehensive risk strategy-information gap decision theory method (2024 · Applied Energy · 被引 27)
- A Microenvironment‐Responsive Graphdiyne‐Iron Nanozyme Hydrogel with Antibacterial and Anti‐Inflammatory Effect for Periodontitis Treatment (2024 · Advanced Healthcare Materials · 被引 26)
- Regulating SLC7A11/GSH/GPX4 axis by glucose dyshomeostasis to simultaneously promote disulfidptosis, cuproptosis and ferroptosis (2025 · Bioactive Materials · 被引 20)